Therapy with hyperimmune plasma from recovered COVID19 patients has been suggested as a possible therapeutic approach. Intravenous immunoglobulins (IVIg) may harbour some protective effect. Patients undergoing IVIg or SCIg chronic treatments may have a reduced risk of contracting COVID-19 infection compared to patients receiving other immune therapies or no therapy.
High-dose immunoglobulin pulse therapy and risk of Covid19 infection / Prada, V.; Benedetti, L.; Cocito, D.; Briani, C.; Nobile Orazio, E.; Gallia, F.; Antonini, G.; Manganelli, F.; Fabrizi, G. M.; Germano, F.; Grandis, M.; Schenone, A.. - In: JOURNAL OF NEUROLOGY. - ISSN 0340-5354. - (2020), pp. 1-3. [10.1007/s00415-020-10146-5]
High-dose immunoglobulin pulse therapy and risk of Covid19 infection
Antonini G.;
2020
Abstract
Therapy with hyperimmune plasma from recovered COVID19 patients has been suggested as a possible therapeutic approach. Intravenous immunoglobulins (IVIg) may harbour some protective effect. Patients undergoing IVIg or SCIg chronic treatments may have a reduced risk of contracting COVID-19 infection compared to patients receiving other immune therapies or no therapy.| File | Dimensione | Formato | |
|---|---|---|---|
|
Prada_High-dose-immunoglobulin_2020.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
426.27 kB
Formato
Adobe PDF
|
426.27 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
